These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 10064002

  • 1. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M, Finazzi G, Bevers EM, Barbui T.
    Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991
    [Abstract] [Full Text] [Related]

  • 5. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Jul 15; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 6. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V, Balestrieri G, Tincani A, Spatola L, Biasiolo A, Brocco T.
    Thromb Haemost; 1997 Jan 15; 77(1):123-6. PubMed ID: 9031461
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA, Krilis SA.
    Thromb Haemost; 1998 Aug 15; 80(2):250-7. PubMed ID: 9716148
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M, Ruggeri L, Barbui T.
    Blood; 1998 Mar 15; 91(6):1999-2004. PubMed ID: 9490682
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 15; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 14. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A, Italian Federation of Anticoagulation Clinics (FCSA).
    Thromb Res; 2007 Dec 15; 120(1):127-33. PubMed ID: 17020782
    [Abstract] [Full Text] [Related]

  • 15. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
    Cojocaru IM, Cojocaru M, Tănăsescu R, Burcin C, Mitu AC, Iliescu I, Dumitrescu L, Pavel I, Silosi I.
    Rom J Intern Med; 2008 Dec 15; 46(4):337-41. PubMed ID: 19480300
    [Abstract] [Full Text] [Related]

  • 16. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI.
    Korean J Lab Med; 2009 Dec 15; 29(6):497-504. PubMed ID: 20046079
    [Abstract] [Full Text] [Related]

  • 17. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E, Saracino MA, Simioni P, Scarano L, Girolami B, Girolami A.
    Clin Lab Haematol; 1995 Sep 15; 17(3):231-5. PubMed ID: 8719896
    [Abstract] [Full Text] [Related]

  • 18. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T.
    Arthritis Rheum; 2000 Sep 15; 43(9):1982-93. PubMed ID: 11014348
    [Abstract] [Full Text] [Related]

  • 19. A functional coagulation test to identify anti-beta2-glycoprotein I dependent lupus anticoagulants.
    Devreese KM.
    Thromb Res; 2007 Sep 15; 119(6):753-9. PubMed ID: 16842842
    [Abstract] [Full Text] [Related]

  • 20. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL.
    Br J Biomed Sci; 1997 Dec 15; 54(4):287-98. PubMed ID: 9624740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.